279 related articles for article (PubMed ID: 27275742)
1. Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
Auld AF; Blain M; Ekra KA; Kouakou JS; Ettiègne-Traoré V; Tuho MZ; Mohamed F; Shiraishi RW; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
PLoS One; 2016; 11(6):e0157059. PubMed ID: 27275742
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
[TBL] [Abstract][Full Text] [Related]
3. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.
Auld AF; Mbofana F; Shiraishi RW; Alfredo C; Sanchez M; Ellerbrock TV; Nelson LJ
PLoS One; 2013; 8(1):e54665. PubMed ID: 23349948
[TBL] [Abstract][Full Text] [Related]
4. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
[TBL] [Abstract][Full Text] [Related]
6. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
7. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
8. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
[TBL] [Abstract][Full Text] [Related]
10. Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.
Abo Y; Zannou Djimon M; Messou E; Balestre E; Kouakou M; Akakpo J; Ahouada C; de Rekeneire N; Dabis F; Lewden C; Minga A;
BMC Infect Dis; 2015 Apr; 15():176. PubMed ID: 25885859
[TBL] [Abstract][Full Text] [Related]
11. Use of pre-ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire.
Minchella PA; Adjé-Touré C; Zhang G; Tehe A; Hedje J; Rottinghaus ER; Natacha K; Diallo K; Ouedraogo GL; Nkengasong JN
Trop Med Int Health; 2020 Apr; 25(4):408-413. PubMed ID: 31960558
[TBL] [Abstract][Full Text] [Related]
12. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya.
Owiti P; Onyango D; Momanyi R; Harries AD
BMC Public Health; 2019 Jan; 19(1):29. PubMed ID: 30621655
[TBL] [Abstract][Full Text] [Related]
13. Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.
Danel C; Kabran M; Inwoley A; Badje A; Herrmann JL; Moh R; Lecarrou J; Gabillard D; Ntakpe JB; Deschamps N; Ouattara E; Perronne C; Eholie S; Anglaret X
PLoS One; 2014; 9(10):e107245. PubMed ID: 25330161
[TBL] [Abstract][Full Text] [Related]
14. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
[TBL] [Abstract][Full Text] [Related]
15. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
Bachmann MO; Timmerman V; Fairall LR
AIDS; 2015 Nov; 29(17):2261-8. PubMed ID: 26544699
[TBL] [Abstract][Full Text] [Related]
17. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
Alvarez-Uria G; Pakam R; Midde M; Naik PK
J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
[TBL] [Abstract][Full Text] [Related]
18. Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008.
Abo Y; Minga A; Menan H; Danel C; Ouassa T; Dohoun L; Bomisso G; Tanoh A; Messou E; Eholié S; Lewden C; Anglaret X
BMC Infect Dis; 2013 Dec; 13():607. PubMed ID: 24373303
[TBL] [Abstract][Full Text] [Related]
19. Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.
Minga A; Danel C; Abo Y; Dohoun L; Bonard D; Coulibaly A; Duvignac J; Dabis F; Salamon R; Anglaret X;
Bull World Health Organ; 2007 Feb; 85(2):116-23. PubMed ID: 17308732
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy.
Bakeera-Kitaka S; Conesa-Botella A; Dhabangi A; Maganda A; Kekitiinwa A; Colebunders R; Boulware DR
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1082-6. PubMed ID: 21740672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
